Naproxen

Product NDC
0093-1005
11-digit product format
000931005
Labeler code
0093
Product ID
0093-1005_7adf6304-d32e-4642-94dc-5f2d906b9a27
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Naproxen
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Labeler
Teva Pharmaceuticals USA, Inc.
Application
ANDA075227
Marketing category
ANDA
Marketing start
1998-07-31
Marketing end
0000-00-00
Substance
NAPROXEN
Active strength
375 mg/1
Pharmacologic classes
Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fef6ad89-235f-4274-ba49-a8e53642473eProduct name220250225
594e2c86-3079-4e6e-96c9-48f7a8afc78dProduct name120230718
351abe41-466c-4dd8-840a-0fdb68318bd5Product name120230316
87fed3e6-8fba-48ef-96b0-3a7fb54b96ffProduct name320230306
b5fdaaec-7251-4da6-9cb2-4e9e76939ec8Product name120200623
e76dbbc1-775d-722c-08ff-ed45e8a80defProduct name320181002
6f4f4521-fd56-1ae6-888b-3b021bd75c7cProduct name120140508
ce67e27d-1d21-5465-4409-b0662dd99d4dProduct name120140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0093-1005-01EA - Each0093-100568c0cc8d-747a-412c-b895-74fd0849d5d812012-07-24
0093-1005-05EA - Each0093-1005dd8fe5de-07d1-4605-82e1-a1645799811712012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
NAPROXENACTIVE INGREDIENT57Y76R9ATQNAPROXEN TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]1
NAPROXENACTIVE INGREDIENT57Y76R9ATQNAPROXEN TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP]1
NAPROXENACTIVE MOIETY57Y76R9ATQNAPROXEN TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP]1
NAPROXENACTIVE MOIETY57Y76R9ATQNAPROXEN TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]1
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O6933NAPROXEN TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48NAPROXEN TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48NAPROXEN TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP]1
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKNAPROXEN TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP]1
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKNAPROXEN TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30NAPROXEN TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30NAPROXEN TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP]1
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE AINACTIVE INGREDIENTNX76LV5T8JNAPROXEN TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]1
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE AINACTIVE INGREDIENTNX76LV5T8JNAPROXEN TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP]1
POVIDONEINACTIVE INGREDIENTFZ989GH94ENAPROXEN TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP]1
POVIDONE K90INACTIVE INGREDIENTRDH86HJV5ZNAPROXEN TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3NAPROXEN TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]1
SHELLACINACTIVE INGREDIENT46N107B71ONAPROXEN TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJNAPROXEN TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJNAPROXEN TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP]1
TALCINACTIVE INGREDIENT7SEV7J4R1UNAPROXEN TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP]1
TALCINACTIVE INGREDIENT7SEV7J4R1UNAPROXEN TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPNAPROXEN TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPNAPROXEN TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]1
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMNAPROXEN TABLET, DELAYED RELEASE [REBEL DISTRIBUTORS CORP]1
TRIETHYL CITRATEINACTIVE INGREDIENT8Z96QXD6UMNAPROXEN TABLET, DELAYED RELEASE [AIDAREX PHARMACEUTICALS LLC]1

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
603103naproxen 375 MG Delayed Release Oral TabletPSN7df1152f-50c0-0571-e053-2991aa0a44372
603103naproxen 375 MG Delayed Release Oral TabletSCD7df1152f-50c0-0571-e053-2991aa0a44372
603103naproxen 375 MG (as naproxen sodium 413 MG) Delayed Release Oral TabletSY7df1152f-50c0-0571-e053-2991aa0a44372
603103naproxen 375 MG Delayed Release Oral TabletPSN14e4b008-ae31-4b40-a227-1445367e09ed1
311915naproxen 500 MG Delayed Release Oral TabletPSN14e4b008-ae31-4b40-a227-1445367e09ed1
311915naproxen 500 MG Delayed Release Oral TabletPSNafebcc90-e2b5-416d-a041-db2dd593a6481
603103naproxen 375 MG Delayed Release Oral TabletSCD14e4b008-ae31-4b40-a227-1445367e09ed1
311915naproxen 500 MG Delayed Release Oral TabletSCD14e4b008-ae31-4b40-a227-1445367e09ed1
311915naproxen 500 MG Delayed Release Oral TabletSCDafebcc90-e2b5-416d-a041-db2dd593a6481
311915naproxen (as naproxen sodium) 500 MG Delayed Release Oral TabletSY14e4b008-ae31-4b40-a227-1445367e09ed1
311915naproxen (as naproxen sodium) 500 MG Delayed Release Oral TabletSYafebcc90-e2b5-416d-a041-db2dd593a6481
603103naproxen 375 MG (as naproxen sodium 413 MG) Delayed Release Oral TabletSY14e4b008-ae31-4b40-a227-1445367e09ed1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0093-1005-0100093100501100 TABLET, DELAYED RELEASE in 1 BOTTLE (0093-1005-01) 1998-07-310000-00-00NoNoCurrent
0093-1005-0500093100505500 TABLET, DELAYED RELEASE in 1 BOTTLE (0093-1005-05) 1998-07-310000-00-00NoNoCurrent